Jacob Torres
Affiliations: | 2011-2017 | Department of Molecular, Cellular & Developmental Biology | University of California, Santa Barbara, Santa Barbara, CA, United States |
Google:
"Jacob Torres"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Messing M, Torres JA, Holznecht N, et al. (2024) Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression. Nutrients. 16 |
| Torres JA, Holznecht N, Asplund DA, et al. (2024) β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease. Iscience. 27: 110773 |
| Torres JA, Holznecht N, Asplund DA, et al. (2023) A Combination of ß-Hydroxybutyrate and Citrate Ameliorates Disease Progression in a Rat Model of Polycystic Kidney Disease. American Journal of Physiology. Renal Physiology |
| Cukoski S, Lindemann CH, Arjune S, et al. (2023) Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial. Cell Reports. Medicine. 101283 |
| Tonum K, Srimai N, Chabang N, et al. (2022) Pharmacological Effects of Panduratin A on Renal Cyst Development in In Vitro and In Vivo Models of Polycystic Kidney Disease. International Journal of Molecular Sciences. 23 |
| Strubl S, Oehm S, Torres JA, et al. (2021) Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects. Clinical Kidney Journal. 15: 1079-1092 |
| Strubl S, Torres JA, Spindt AK, et al. (2020) STAT signaling in polycystic kidney disease. Cellular Signalling. 72: 109639 |
| Torres JA, Kruger SL, Broderick C, et al. (2019) Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease. Cell Metabolism |
| Torres JA, Rezaei M, Broderick C, et al. (2019) Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease. The Journal of Clinical Investigation. 130 |
| Weimbs T, Shillingford JM, Torres J, et al. (2018) Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease. Clinical Kidney Journal. 11: i27-i38 |